|
TAB3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67021951824609E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01758618093118E-12 |
| Normal-vs-Stage2 |
5.49260000037854E-07 |
| Normal-vs-Stage3 |
2.34280039812518E-10 |
| Normal-vs-Stage4 |
3.69509978170868E-10 |
| Stage1-vs-Stage2 |
9.843600E-01 |
| Stage1-vs-Stage3 |
4.367200E-01 |
| Stage1-vs-Stage4 |
1.372350E-01 |
| Stage2-vs-Stage3 |
6.283800E-01 |
| Stage2-vs-Stage4 |
2.596000E-01 |
| Stage3-vs-Stage4 |
4.377600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.48894263374677E-13 |
| Normal-vs-AfricanAmerican |
1.576970E-04 |
| Normal-vs-Asian |
3.13569999965679E-07 |
| Caucasian-vs-AfricanAmerican |
7.220200E-01 |
| Caucasian-vs-Asian |
9.864200E-01 |
| AfricanAmerican-vs-Asian |
7.785400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.39635003349304E-12 |
| Normal-vs-Female |
2.65831801016247E-12 |
| Male-vs-Female |
5.797400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.34919964089875E-10 |
| Normal-vs-Age(41-60Yrs) |
2.17414974912344E-12 |
| Normal-vs-Age(61-80Yrs) |
9.4506003023298E-10 |
| Normal-vs-Age(81-100Yrs) |
6.186700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.121000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.128800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.788200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.892000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.893600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.075800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.295200E-01 |
| Classical-VS-Follicular |
7.563700E-03 |
| Classical-VS-Other |
2.600800E-01 |
| Classical-VS-Normal |
8.54379900161462E-11 |
| Tall-VS-Follicular |
3.917600E-01 |
| Tall-VS-Other |
4.502800E-01 |
| Tall-VS-Normal |
2.14700000000789E-06 |
| Follicular-VS-Other |
8.381600E-01 |
| Follicular-VS-Normal |
3.68940433759235E-11 |
| Other-VS-Normal |
1.401820E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.28996813231197E-12 |
| Normal-vs-N1 |
8.03970001683751E-09 |
| N0-vs-N1 |
7.513200E-01 |
|
|
